Unknown

Dataset Information

0

Common ?2A and ?2C adrenergic receptor polymorphisms do not affect plasma membrane trafficking.


ABSTRACT: Various naturally occurring polymorphic forms of human G protein-coupled receptors (GPCRs) have been identified and linked to diverse pathological diseases, including receptors for vasopressin type 2 (nephrogenic diabetes insipidus) and gonadotropin releasing hormone (hypogonadotropic hypogonadism). In most cases, polymorphic amino acid mutations disrupt protein folding, altering receptor function as well as plasma membrane expression. Other pathological GPCR variants have been found that do not alter receptor function, but instead affect only plasma membrane trafficking (e.g., delta opiate and histamine type 1 receptors). Thus, altered membrane trafficking with retained receptor function may be another mechanism causing polymorphic GPCR dysfunction. Two common human ?2A and ?2C adrenergic receptor (AR) variants have been identified (?2A N251K and ?2C ?322-325 ARs), but pharmacological analysis of ligand binding and second messenger signaling has not consistently demonstrated altered receptor function. However, possible alterations in plasma membrane trafficking have not been investigated. We utilized a systematic approach previously developed for the study of GPCR trafficking motifs and accessory proteins to assess whether these ?2 AR variants affected intracellular trafficking or plasma membrane expression. By combining immunofluorescent microscopy, glycosidic processing analysis, and quantitative fluorescent-activated cell sorting (FACS), we demonstrate that neither variant receptor had altered intracellular localization, glycosylation, nor plasma membrane expression compared to wild-type ?2 ARs. Therefore, pathopharmacological properties of ?2A N251K and ?2C ?322-325 ARs do not appear to be due to altered receptor pharmacology or plasma membrane trafficking, but may involve interactions with other intracellular signaling cascades or proteins.

SUBMITTER: Hurt CM 

PROVIDER: S-EPMC4035122 | biostudies-other | 2014 Jun

REPOSITORIES: biostudies-other

altmetric image

Publications

Common α2A and α2C adrenergic receptor polymorphisms do not affect plasma membrane trafficking.

Hurt Carl M CM   Sorensen Matt W MW   Angelotti Timothy T  

Naunyn-Schmiedeberg's archives of pharmacology 20140319 6


Various naturally occurring polymorphic forms of human G protein-coupled receptors (GPCRs) have been identified and linked to diverse pathological diseases, including receptors for vasopressin type 2 (nephrogenic diabetes insipidus) and gonadotropin releasing hormone (hypogonadotropic hypogonadism). In most cases, polymorphic amino acid mutations disrupt protein folding, altering receptor function as well as plasma membrane expression. Other pathological GPCR variants have been found that do not  ...[more]

Similar Datasets

| S-EPMC3148834 | biostudies-literature
| S-EPMC2724686 | biostudies-literature
| S-EPMC3781101 | biostudies-literature
| S-EPMC6988844 | biostudies-literature
| S-EPMC2276349 | biostudies-literature
| S-EPMC3633790 | biostudies-literature
| S-EPMC4260556 | biostudies-literature
| S-EPMC10093020 | biostudies-literature
| S-EPMC2630185 | biostudies-literature
| S-EPMC9925724 | biostudies-literature